|
Should EOAD patients be included in clinical trials?
Kinga Szigeti, Rachelle S Doody Alzheimer's Research & Therapy 2011, 3:4 (8 February 2011)
Abstract | Full text | PDF
| PubMed
|
Editor’s summary
Szigeti and Doody suggest that enrolling early-onset Alzheimer’s (EOAD) disease patients in clinical trials would help to detect a signal of efficacy, especially for amyloid-based therapies.
|